Urologix Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Mar '15 Mar 31, 2015	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010
Revenue	12	14.01	16.48	17.03	12.57	14.77
Revenue Growth (YoY)	-19.41%	-15.00%	-3.19%	35.45%	-14.89%	15.25%
Cost of Revenue	6.34	8.12	8.13	8.65	6.03	6.57
Gross Profit	5.66	5.9	8.35	8.38	6.54	8.2
Selling, General & Admin	5.14	8.15	10.23	9.97	7.9	8.6
Research & Development	1.31	1.63	2.27	2.19	2.24	1.83
Amortization of Goodwill & Intangibles	0.08	0.1	0.1	0.09	0.02	0.02
Operating Expenses	6.53	9.87	12.61	12.25	10.16	10.46
Operating Income	-0.87	-3.97	-4.26	-3.87	-3.62	-2.26
Interest Expense	-0.77	-0.69	-0.56	-0.48	-	-
Interest & Investment Income	-	-	-	-	0	-
Currency Exchange Gain (Loss)	-0.01	-0	-0.01	-0.01	-	-
EBT Excluding Unusual Items	-1.66	-4.67	-4.82	-4.36	-3.62	-2.26
Merger & Restructuring Charges	-0.03	-0.03	-	-0.29	-0.1	-
Impairment of Goodwill	-3.04	-3.04	-	-	-	-
Gain (Loss) on Sale of Investments	-	-	0.32	-	-	-
Asset Writedown	-	-	-0.43	-	-	-
Other Unusual Items	-	0.11	0.65	0.01	-	-
Pretax Income	-4.72	-7.62	-4.28	-4.64	-3.73	-2.26
Income Tax Expense	-0.05	-0.02	0.01	0.06	0.01	-0.09
Net Income	-4.67	-7.61	-4.29	-4.7	-3.73	-2.17
Net Income to Common	-4.67	-7.61	-4.29	-4.7	-3.73	-2.17
Shares Outstanding (Basic)	22	21	21	15	15	15
Shares Outstanding (Diluted)	22	21	21	15	15	15
Shares Change (YoY)	2.26%	2.49%	40.45%	1.27%	0.33%	0.27%
EPS (Basic)	-0.22	-0.36	-0.21	-0.32	-0.26	-0.15
EPS (Diluted)	-0.22	-0.36	-0.21	-0.32	-0.26	-0.15
Free Cash Flow	-0.28	-1.56	-2.04	-0.77	-2.64	-1.34
Free Cash Flow Per Share	-0.01	-0.07	-0.10	-0.05	-0.18	-0.09
Gross Margin	47.13%	42.08%	50.66%	49.23%	52.03%	55.53%
Operating Margin	-7.28%	-28.35%	-25.82%	-22.72%	-28.82%	-15.28%
Profit Margin	-38.90%	-54.30%	-26.04%	-27.57%	-29.70%	-14.68%
Free Cash Flow Margin	-2.29%	-11.15%	-12.36%	-4.52%	-21.02%	-9.04%
EBITDA	-0.37	-3.39	-3.58	-3.17	-3.06	-1.46
EBITDA Margin	-3.11%	-24.16%	-21.73%	-18.63%	-24.33%	-9.91%
D&A For EBITDA	0.5	0.59	0.67	0.7	0.57	0.79
EBIT	-0.87	-3.97	-4.26	-3.87	-3.62	-2.26
EBIT Margin	-7.28%	-28.35%	-25.82%	-22.72%	-28.82%	-15.28%

Updated May 14, 2015. Source: S&P Global Market Intelligence. Standard template. Financial Sources.